查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462942

免疫細胞工程市場，按細胞類型、按產品類型、按疾病適應症、按應用、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Immune Cell Engineering Market, By Cell Type, By Product Type, By Disease Indication, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 385 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年免疫細胞工程市場規模為29.225億美元，2024年至2032年複合CAGR為20.5%。

免疫細胞工程市場-市場動態

對先進細胞療法的需求不斷增加，推動市場需求

鑑於對先進細胞療法的需求不斷成長，免疫細胞工程的全球市場為該領域的公司提供了利潤豐厚的前景。使用工程化 T 細胞或嵌合抗原受體 (CAR) T 細胞的療法在癌症治療的臨床試驗中已顯示出有希望的結果。主要市場促進因素包括主要製藥公司對免疫療法的大量投資以及專注於免疫細胞療法的臨床試驗的擴大。基因編輯、細胞分離和擴增技術的持續進步極大地推動了免疫細胞工程領域的擴張。 CRISPR/Cas9等有效基因編輯工具的出現促進了免疫細胞的精確且更安全的改變。同時，微流體和高通量分析等技術的進步正在簡化細胞工程過程。此外，對免疫細胞訊號通路和相互作用的深入理解正在促進更有效的免疫細胞療法的開發。這些持續的技術進步預計將拓寬工程免疫細胞的視野和實用性。

免疫細胞工程市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 20.5% 左右的CAGR成長

根據細胞類型細分，預計 T 細胞將在 2023 年顯示最大的市場佔有率

從應用細分來看，細胞治療與再生醫學是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

免疫細胞工程市場-細分分析：

全球免疫細胞工程市場根據細胞類型、產品類型、疾病適應症、應用和區域進行細分。

市場依細胞類型分為六類：T 細胞、NK 細胞、樹突狀細胞、腫瘤細胞、幹細胞等。在免疫細胞工程市場中，T細胞在細胞類型中佔據主導地位。 T 細胞是免疫系統中的關鍵角色，具有識別和消除感染細胞或癌細胞的能力。它們的主導地位源於其多功能性以及在各種免疫療法中的關鍵作用，特別是在 CAR T 細胞治療中。該療法涉及修改 T 細胞以表達嵌合抗原受體 (CAR)，使它們能夠精確瞄準並摧毀癌細胞。隨著 CAR T 細胞療法在癌症治療中越來越受歡迎，對工程 T 細胞的需求持續成長，推動了它們在市場上的主導地位。

市場依應用分為三類：研究應用、細胞治療及再生醫學等。在應用方面，細胞治療和再生醫學佔據主導地位。這種主導地位歸因於免疫細胞工程在開發針對各種疾病的新型細胞療法方面的變革潛力。細胞療法利用 T 細胞和幹細胞等工程免疫細胞的治療潛力來治療癌症、自體免疫疾病和再生醫學應用。尤其是 CAR T 細胞療法，透過提供具有顯著臨床效果的個人化和標靶治療，徹底改變了癌症治療。此外，再生醫學領域利用工程免疫細胞來修復和再生受損的組織和器官，為創新治療方法鋪平了道路。免疫細胞療法的重大臨床成功和廣泛的治療應用使細胞治療和再生醫學成為免疫細胞工程市場的主導應用。

免疫細胞工程市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

免疫細胞工程市場-競爭格局：

免疫細胞工程公司正在採取專注於創新、協作和市場擴張的策略。他們投資研究以增強 CAR T 細胞療法等療法，建立技術交流合作夥伴關係，並拓展新市場。這些努力旨在解決個人化治療開發的複雜性、擴大生產能力並降低成本，最終目標是讓更多患者獲得治療。此外，他們利用不斷成長的臨床證據和合作夥伴關係來推動免疫細胞工程的長期市場發展。

2023 年 8 月，製藥公司 Astellas Pharma, Inc. 與臨床階段公司 Poseida Therapeutics 達成策略性投資協議，以推動癌細胞療法的開發。安斯泰來承諾總共投入 5000 萬美元，包括一次性付款 2500 萬美元，以獲得獨家談判權和優先拒絕許可 Poseida 的臨床階段項目之一 P-MUC1C-ALLO1。本計畫重點在於開發針對各種實體腫瘤適應症的同種異體嵌合抗原 T 細胞 (CAR-T) 療法。

目錄

第1章：免疫細胞工程市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按細胞類型分類的免疫細胞工程市場片段
    • 按產品類型分類的免疫細胞工程市場片段
    • 按疾病適應症分類的免疫細胞工程市場片段
    • 免疫細胞工程市場片段（依應用）
    • 按國家/地區分類的免疫細胞工程市場片段
    • 按地區分類的免疫細胞工程市場片段
  • 競爭洞察

第 3 章：免疫細胞工程主要市場趨勢

  • 免疫細胞工程市場促進因素
    • 市場促進因素的影響分析
  • 免疫細胞工程市場限制
    • 市場限制影響分析
  • 免疫細胞工程市場機會
  • 免疫細胞工程市場未來趨勢

第4章：免疫細胞工程產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：免疫細胞工程市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：免疫細胞工程市場格局

  • 2023 年免疫細胞工程市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：免疫細胞工程市場 - 按細胞類型

  • 概述
    • 按電池類型分類的細分市場佔有率分析
    • T細胞
    • 自然殺手細胞
    • 樹突狀細胞
    • 腫瘤細胞
    • 幹細胞
    • 其他

第 8 章：免疫細胞工程市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 耗材
    • 儀器
    • 軟體

第 9 章：免疫細胞工程市場 - 按疾病適應症

  • 概述
    • 按疾病適應症分類的細分市場佔有率分析
    • 心血管疾病
    • 呼吸疾病
    • 傳染性疾病
    • 癌症
    • 神經系統疾病
    • 其他

第 10 章：免疫細胞工程市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 研究應用
    • 細胞治療與再生醫學
    • 其他

第 11 章：免疫細胞工程市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美免疫細胞工程主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按電池類型）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按疾病適應症）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲免疫細胞工程主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按電池類型）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按疾病適應症）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太區免疫細胞工程主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按電池類型）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依疾病適應症）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫細胞工程主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按電池類型）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按疾病適應症）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲免疫細胞工程主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按電池類型）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（依疾病指示）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第12章：免疫細胞工程產業主要供應商分析

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Lonza
    • Miltenyi Biotec
    • Takara Bio Inc.
    • Sartorius CellGenix GmbH
    • FUJIFILM Irvine Scientific
    • Agilent Technologies, Inc.
    • Bio-Techne
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Charles River Laboratories
    • Creative Bioarray
    • Sartorius AG
    • Novogene Co, Ltd.
    • AGC Biologics
    • Catalent, Inc.
    • WuXi AppTec
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2400

REPORT HIGHLIGHT

Immune Cell Engineering Market size was valued at USD 2,922.5 Million in 2023, expanding at a CAGR of 20.5% from 2024 to 2032.

Immune cell engineering involves the modification of immune cells like T cells, NK cells, and dendritic cells for both research and therapeutic purposes. These applications range from the development of immunotherapies such as CAR T-cell therapy to the study of immune responses and drug discovery.

Immune Cell Engineering Market- Market Dynamics

Increasing demand for advanced cell therapies to propel market demand

The global market for immune cell engineering offers lucrative prospects for companies operating in the field, given the increasing demand for advanced cell therapies. Therapies employing engineered T cells or chimeric antigen receptor (CAR) T cells have demonstrated promising outcomes in clinical trials for cancer treatment. Key market drivers include significant investments in immunotherapies by major pharmaceutical firms and the expansion of clinical trials focusing on immune cell therapies. The ongoing progress in gene editing, cell isolation, and expansion technologies is substantially fueling the expansion of the immune cell engineering sector. The emergence of effective gene editing tools such as CRISPR/Cas9 has facilitated precise and safer alterations in immune cells. Concurrently, advancements in technologies like microfluidics and high-throughput assays are streamlining cell engineering processes. Moreover, the deepening comprehension of immune cell signaling pathways and interactions is empowering the development of more potent immune cell therapies. These continual technological advancements are anticipated to broaden the horizons and utility of engineered immune cells.

Immune Cell Engineering Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2024-2032)

Based on cell type segmentation, T cells was predicted to show maximum market share in the year 2023

Based on application segmentation, Cell Therapy & Regenerative Medicine was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Immune Cell Engineering Market- Segmentation Analysis:

The Global Immune Cell Engineering Market is segmented on the basis of Cell Type, Product Type, Disease Indication, Application, and Region.

The market is divided into six categories based on Cell Type: T Cells, NK Cells, Dendritic Cells, Tumor Cells, Stem Cells, and others. In the Immune Cell Engineering market, T cells dominate among cell types. T cells are pivotal players in the immune system, possessing the capability to recognize and eliminate infected or cancerous cells. Their dominance stems from their versatile nature and crucial role in various immunotherapeutic approaches, particularly in CAR T-cell therapy. This therapy involves modifying T cells to express chimeric antigen receptors (CARs), enabling them to target and destroy cancer cells with precision. As CAR T-cell therapy gains traction in cancer treatment, the demand for engineered T cells continues to rise, driving their dominance in the market.

The market is divided into three categories based on application: Research Applications, Cell Therapy & Regenerative Medicine, and others. In terms of applications, Cell Therapy & Regenerative Medicine stands out as the dominating segment. This dominance is attributed to the transformative potential of immune cell engineering in developing novel cell-based therapies for various diseases. Cell therapy harnesses the therapeutic potential of engineered immune cells, such as T cells and stem cells, to treat cancer, autoimmune disorders, and regenerative medicine applications. CAR T-cell therapy, in particular, has revolutionized cancer treatment by offering personalized and targeted therapies with remarkable clinical outcomes. Additionally, the field of regenerative medicine utilizes engineered immune cells to repair and regenerate damaged tissues and organs, paving the way for innovative treatment approaches. The significant clinical success and broad therapeutic applications of immune cell-based therapies position Cell Therapy & Regenerative Medicine as the dominant application in the Immune Cell Engineering market.

Immune Cell Engineering Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Immune Cell Engineering Market- Competitive Landscape:

Immune cell engineering companies are adopting strategies focused on innovation, collaboration, and market expansion. They invest in research to enhance therapies like CAR T-cell therapy, forge partnerships for technology exchange, and expand into new markets. These efforts aim to address complexities in personalized therapy development, scale up production capacity, and reduce costs, ultimately aiming for broader patient access. Additionally, they leverage growing clinical evidence and partnerships to drive long-term market evolution in immune cell engineering.Recent Developments:

In August 2023, Astellas Pharma, Inc., a pharmaceutical company, and Poseida Therapeutics, a clinical-stage company, forged a strategic investment agreement to advance the development of cell therapies for cancer. Astellas committed a total of US$ 50 million, including a one-time US$ 25 million payment, to gain exclusive negotiation rights and first refusal to license one of Poseida's clinical-stage programs, P-MUC1C-ALLO1. This program focuses on developing an allogeneic chimeric antigen T cell (CAR-T) therapy for various solid tumor indications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNE CELL ENGINEERING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Merck KGaA

Danaher Corporation

Lonza

Miltenyi Biotec

Takara Bio Inc.

Sartorius CellGenix GmbH

FUJIFILM Irvine Scientific

Agilent Technologies, Inc.

Bio-Techne

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

Charles River Laboratories

Creative Bioarray

Sartorius AG

Novogene Co, Ltd.

AGC Biologics

Catalent, Inc.

WuXi AppTec

Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

  • T Cells
  • NK Cells
  • Dendritic Cells
  • Tumor Cells
  • Stem Cells
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Consumables
  • Instruments
  • Software

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Cancer
  • Neurological Diseases
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research Applications
  • Cell Therapy & Regenerative Medicine
  • Others

GLOBAL IMMUNE CELL ENGINEERING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Immune Cell Engineering Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Immune Cell Engineering Market Snippet by Cell Type
    • 2.1.2.Immune Cell Engineering Market Snippet by Product Type
    • 2.1.3.Immune Cell Engineering Market Snippet by Disease Indication
    • 2.1.4.Immune Cell Engineering Market Snippet by Application
    • 2.1.5.Immune Cell Engineering Market Snippet by Country
    • 2.1.6.Immune Cell Engineering Market Snippet by Region
  • 2.2.Competitive Insights

3.Immune Cell Engineering Key Market Trends

  • 3.1.Immune Cell Engineering Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Immune Cell Engineering Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Immune Cell Engineering Market Opportunities
  • 3.4.Immune Cell Engineering Market Future Trends

4.Immune Cell Engineering Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Immune Cell Engineering Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Immune Cell Engineering Market Landscape

  • 6.1.Immune Cell Engineering Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Immune Cell Engineering Market - By Cell Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 7.1.2.T Cells
    • 7.1.3.NK Cells
    • 7.1.4.Dendritic Cells
    • 7.1.5.Tumor Cells
    • 7.1.6.Stem Cells
    • 7.1.7.Others

8.Immune Cell Engineering Market - By Product Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 8.1.2.Consumables
    • 8.1.3.Instruments
    • 8.1.4.Software

9.Immune Cell Engineering Market - By Disease Indication

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 9.1.2.Cardiovascular Diseases
    • 9.1.3.Respiratory Diseases
    • 9.1.4.Infectious Diseases
    • 9.1.5.Cancer
    • 9.1.6.Neurological Diseases
    • 9.1.7.Others

10.Immune Cell Engineering Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Research Applications
    • 10.1.3.Cell Therapy & Regenerative Medicine
    • 10.1.4.Others

11.Immune Cell Engineering Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Immune Cell Engineering Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Immune Cell Engineering Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Immune Cell Engineering Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Immune Cell Engineering Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Immune Cell Engineering Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Immune Cell Engineering Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Thermo Fisher Scientific Inc.
    • 12.2.2.Merck KGaA
    • 12.2.3.Danaher Corporation
    • 12.2.4.Lonza
    • 12.2.5.Miltenyi Biotec
    • 12.2.6.Takara Bio Inc.
    • 12.2.7.Sartorius CellGenix GmbH
    • 12.2.8.FUJIFILM Irvine Scientific
    • 12.2.9.Agilent Technologies, Inc.
    • 12.2.10.Bio-Techne
    • 12.2.11.Bio-Rad Laboratories, Inc.
    • 12.2.12.Becton, Dickinson and Company
    • 12.2.13.Charles River Laboratories
    • 12.2.14.Creative Bioarray
    • 12.2.15.Sartorius AG
    • 12.2.16.Novogene Co, Ltd.
    • 12.2.17.AGC Biologics
    • 12.2.18.Catalent, Inc.
    • 12.2.19.WuXi AppTec
    • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Immune Cell Engineering Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Immune Cell Engineering Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Immune Cell Engineering Market, by Product Type 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Disease Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Immune Cell Engineering Market, by Disease Indication 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Immune Cell Engineering Market, by Application 2019-2032 (USD Million)
  • TABLE Immune Cell Engineering Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Immune Cell Engineering Market, by Region 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE North America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Europe Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Latin America Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Immune Cell Engineering Market, by Application, 2019-2032 (USD Million)